keyword
Keywords Levomethadone OR L-Methadone O...

Levomethadone OR L-Methadone OR R-Methadone OR D-Methadone OR S-Methadone

https://read.qxmd.com/read/38651025/maternal-substance-use-and-early-life-adversity-inducing-drug-dependence-in-offspring-interactions-mechanisms-and-treatments
#1
REVIEW
Maysam Fadaei-Kenarsary, Khadijeh Esmaeilpour, Mohammad Shabani, Vahid Sheibani
The likelihood of substance dependency in offspring is increased in cases when there is a family history of drug or alcohol use. Mothering is limited by maternal addiction because of the separation. Maternal separation (MS) leads to the development of behavioural and neuropsychiatric issues in the future. Despite the importance of this issue, empirical investigations of the influences of maternal substance use and separation on substance use problems in offspring are limited, and studies that consider both effects are rare...
February 2024: Addiction & Health
https://read.qxmd.com/read/38646511/editorial-effects-of-perinatal-opioid-exposure-volume-ii
#2
EDITORIAL
Loretta P Finnegan, Henrietta S Bada
No abstract text is available yet for this article.
2024: Frontiers in Pediatrics
https://read.qxmd.com/read/38643530/latinx-harm-reduction-capital-medication-for-opioid-use-disorder-and-nonfatal-overdose-a-structural-equation-model-analysis-among-people-who-use-drugs-in-massachusetts
#3
JOURNAL ARTICLE
Shikhar Shrestha, Thomas J Stopka, Jaclyn M W Hughto, Patricia Case, Wilson R Palacios, Brittni Reilly, Traci C Green
BACKGROUND: We introduce the concept of harm reduction capital (HRCap) as the combination of knowledge, resources, and skills related to substance use risk reduction, which we hypothesize to predict MOUD use and opioid overdose. In this study, we explored the interrelationships between ethnicity, HRCap, nonfatal overdose, and MOUD use among PWUD. METHODS: Between 2017 and 2019, people who currently or in the past used opioids and who lived in Massachusetts completed a one-time survey on substance use history, treatment experiences, and use of harm reduction services...
April 15, 2024: Drug and Alcohol Dependence
https://read.qxmd.com/read/38643529/impact-of-jail-based-methadone-or-buprenorphine-treatment-on-non-fatal-opioid-overdose-after-incarceration
#4
JOURNAL ARTICLE
Teena Cherian, Sungwoo Lim, Monica Katyal, Keith S Goldfeld, Ryan McDonald, Ellen Wiewel, Maria Khan, Noa Krawczyk, Sarah Braunstein, Sean M Murphy, Ali Jalali, Philip J Jeng, Zachary Rosner, Ross MacDonald, Joshua D Lee
BACKGROUND: Non-fatal overdose is a leading predictor of subsequent fatal overdose. For individuals who are incarcerated, the risk of experiencing an overdose is highest when transitioning from a correctional setting to the community. We assessed if enrollment in jail-based medications for opioid use disorder (MOUD) is associated with lower risk of non-fatal opioid overdoses after jail release among individuals with opioid use disorder (OUD). METHODS: This was a retrospective, observational cohort study of adults with OUD who were incarcerated in New York City jails and received MOUD or did not receive any MOUD (out-of-treatment) within the last three days before release to the community in 2011-2017...
March 28, 2024: Drug and Alcohol Dependence
https://read.qxmd.com/read/38642889/a-trial-of-implementation-facilitation-to-increase-timely-admission-to-methadone-treatment
#5
JOURNAL ARTICLE
J Gryczynski, S G Mitchell, M Whitter, D Fuller, M M Mitchell, E J Edelman, R P Schwartz
BACKGROUND: During the ongoing opioid epidemic, some Opioid Treatment Programs (OTPs) are unable to admit program applicants in a timely fashion. Interim methadone (IM) treatment (without routine counseling) is an effective approach to overcome this challenge when counseling capacity is inadequate to permit admissions within 14 days of request. It requires both federal and state approval and has been rarely utilized since its incorporation into the federal OTP regulations in 1993...
April 18, 2024: J Subst Use Addict Treat
https://read.qxmd.com/read/38642310/inpatient-opioid-withdrawal-a-qualitative-study-of-the-patient-perspective
#6
JOURNAL ARTICLE
Danielle M Babbel, Patricia Liu, David R Chen, Valerie M Vaughn, Susan Zickmund, Kennedi Bloomquist, Tobias Zickmund, Elizabeth F Howell, Stacy A Johnson
Opioid withdrawal is common among hospitalized patients. Those with substance use disorders exhibit higher rates of patient-directed discharge. The literature lacks information regarding the patient perspective on opioid withdrawal in the hospital setting. In this study, we aimed to capture the patient-reported experience of opioid withdrawal during hospitalization and its impact on the desire to continue treatment for opioid use disorder after discharge. We performed a single-center qualitative study involving semi-structured interviews of hospitalized patients with opioid use disorder (OUD) experiencing opioid withdrawal...
April 20, 2024: Internal and Emergency Medicine
https://read.qxmd.com/read/38642101/a-rat-model-of-operant-negative-reinforcement-in-opioid-dependent-males-and-females
#7
JOURNAL ARTICLE
Jonathan J Chow, Kayla M Pitts, Jules M Chabot, Rutsuko Ito, Yavin Shaham
RATIONALE AND OBJECTIVE: Avoidance of opioid withdrawal plays a key role in human opioid addiction. Here, we present a procedure for studying operant negative reinforcement in rats that was inspired by primate procedures where opioid-dependent subjects lever-press to prevent naloxone infusions. METHODS: In Experiment 1, we trained rats (n = 30, 15 females) to lever-press to escape and then avoid mild footshocks (0.13-0.27 mA) for 35 days (30 trials/d)...
April 20, 2024: Psychopharmacology
https://read.qxmd.com/read/38606900/stepped-care-for-patients-to-optimize-whole-recovery-sc-powr-an-effectiveness-trial-evaluating-a-stepped-care-model-for-individuals-with-opioid-use-disorder-and-chronic-pain
#8
JOURNAL ARTICLE
Raiza Rossi, Christopher J Cutter, Mark Beitel, Mikah Covelli, David A Fiellin, Robert D Kerns, Svetlana Vassilieva, Deborah Olabisi, Declan T Barry
Many patients who receive treatment for opioid use disorder (OUD) report experiencing chronic pain (CP), which is associated with high levels of ongoing nonmedical opioid use and low retention in OUD treatment. In pilot studies of patients with OUD receiving buprenorphine or methadone who had CP, cognitive behavioral therapy (CBT) attenuated nonmedical opioid use compared with treatment-as-usual (TAU), but patients in both treatment arms exhibited similar pain improvements. Adding exercise and stress reduction to this model may augment pain-related outcomes...
April 12, 2024: Subst Use Addctn J
https://read.qxmd.com/read/38600723/quantitative-determination-of-r-s-methadone-in-human-serum-using-ultra-high-performance-supercritical-fluid-chromatography-tandem-mass-spectrometry-a-method-for-routine-use
#9
JOURNAL ARTICLE
Miriam Hansen, Hilde Havnen, Trine Naalsund Andreassen, Olav Spigset, Solfrid Hegstad
Methadone has two enantiomers, which exhibit differences in pharmacological effects, with R-methadone being the active and S-methadone the inactive enantiomer. A robust, simple and rapid method for chiral separation of the two enantiomers in serum samples using ultra-high performance supercritical fluid chromatography-tandem mass spectrometry (UHPSFC-MSMS) has been developed and validated. Enantiomeric separation was achieved using a Chiralpak IH-3 column with a mobile phase consisting of CO2 and 30mM ammonium acetate in methanol/water (98/2, v/v)...
April 10, 2024: Drug Testing and Analysis
https://read.qxmd.com/read/38599533/clinician-ordering-and-management-patterns-of-urine-toxicology-results-at-a-cancer-center
#10
JOURNAL ARTICLE
Miryam Yusufov, Stacy E F Melanson, Phillip Kang, Benjamin Kematick, Gordon D Schiff, Isaac S Chua
CONTEXT: Opioid therapy is a cornerstone for treatment of cancer-related pain, but standardized management practices for patients with cancer and aberrant urine drug test (UDT) results are lacking. OBJECTIVES: To identify the prevalence of UDT ordering (both screening and definitive testing) in the oncology setting and to examine clinician management practices for patients with cancer on opioid therapy with aberrant definitive UDT results. METHODS: We conducted a retrospective chart review of patients with cancer on opioid therapy at an academic cancer center in the United States...
April 8, 2024: Journal of Pain and Symptom Management
https://read.qxmd.com/read/38594836/two-doses-of-subcutaneous-methadone-for-postoperative-analgesia-in-dogs-undergoing-tibial-plateau-levelling-osteotomies
#11
JOURNAL ARTICLE
D Upchurch, K T T Lin, B KuKanich
OBJECTIVES: To evaluate analgesia, sedation and adverse effects of two doses of subcutaneous methadone in dogs undergoing tibial plateau levelling osteotomy. MATERIALS AND METHODS: Seventeen client-owned dogs undergoing unilateral tibial plateau levelling osteotomy were randomly allocated to receive either 0.25 mg/kg methadone (eight dogs) or 0.5 mg/kg methadone (nine dogs). All dogs were premedicated with methadone and 2 to 6 mcg/kg dexmedetomidine subcutaneously...
April 9, 2024: Journal of Small Animal Practice
https://read.qxmd.com/read/38587730/prescribing-and-acceptance-of-medications-for-opioid-use-disorder-in-va-primary-care-veteran-and-provider-perspectives
#12
JOURNAL ARTICLE
Alicia A Bergman, Rebecca S Oberman, Stephanie L Taylor, Bridget Kranke, Evelyn T Chang
BACKGROUND: Medications to treat opioid use disorder (MOUD) such as buprenorphine/naloxone can effectively treat OUD and reduce opioid-related mortality, but they remain underutilized, especially in non-substance use disorder settings such as primary care (PC). OBJECTIVE: To uncover the factors that can facilitate successful prescribing of MOUD and uptake/acceptance of MOUD by patients in PC settings in the Veterans Health Administration. DESIGN: Semi-structured qualitative telephone interviews with 77 providers (e...
April 8, 2024: Journal of General Internal Medicine
https://read.qxmd.com/read/38570825/commentary-on-schmidt-et-al-informed-patient-preference-and-prioritizing-access-to-medications-for-opioid-use-disorder-for-pregnant-individuals
#13
JOURNAL ARTICLE
Jake R Morgan, Ashley A Leech
No abstract text is available yet for this article.
April 3, 2024: Addiction
https://read.qxmd.com/read/38560623/the-role-of-methadone-in-cardiac-surgery-for-management-of-postoperative-pain
#14
JOURNAL ARTICLE
Jordan N Edwards, Madeline A Whitney, Bradford B Smith, Megan K Fah, Skye A Buckner Petty, Omar Durra, Kristen A Sell-Dottin, Erica Portner, Erica D Wittwer, Adam J Milam
BACKGROUND: This retrospective study evaluated the efficacy and safety of intraoperative methadone compared with short-acting opioids. METHODS: Patients undergoing cardiac surgery with cardiopulmonary bypass ( n =11 967) from 2018 to 2023 from a single health system were categorised into groups based on intraoperative opioid administration: no methadone (Group O), methadone plus other opioids (Group M+O), and methadone only (Group M). RESULTS: Patients in Groups M and M+O had lower mean pain scores until postoperative day (POD) 7 compared with Group O after adjusting for covariates ( P <0...
June 2024: BJA Open
https://read.qxmd.com/read/38558723/methadone-withdrawal-induced-psychosis-a-case-report
#15
Oluwaseun Oke, Marta B Sekh, Bamidele O Johnson, Samuel Adeyemo
Methadone is a synthetic full µ-opioid receptor agonist and N-methyl-D-aspartate antagonist given to patients who have recently stopped using illicit opioids or are tapering off chronic opioid pain medication. Maintenance treatment with methadone is today the most widespread and effective way to treat opiate addiction, which achieves abstinence, decreases morbidity and mortality, improves quality of life, and reduces crime genesis, among other benefits. It is also approved by the Food and Drug Administration for treating moderate-to-severe pain that remains unresponsive to nonopioid medications...
February 2024: Curēus
https://read.qxmd.com/read/38557501/development-and-evaluation-of-a-digital-app-for-patient-self-management-of-opioid-use-disorder-usability-acceptability-and-utility-study
#16
JOURNAL ARTICLE
Van Lewis King, Gregg Siegel, Henry Richard Priesmeyer, Leslie H Siegel, Jennifer S Potter
BACKGROUND: Self-management of opioid use disorder (OUD) is an important component of treatment. Many patients receiving opioid agonist treatment in methadone maintenance treatment settings benefit from counseling treatments to help them improve their recovery skills but have insufficient access to these treatments between clinic appointments. In addition, many addiction medicine clinicians treating patients with OUD in a general medical clinic setting do not have consistent access to counseling referrals for their patients...
April 1, 2024: JMIR Formative Research
https://read.qxmd.com/read/38551080/perceptions-of-community-corrections-and-treatment-experience-a-qualitative-study-among-people-with-incarceration-histories-receiving-outpatient-methadone-treatment
#17
JOURNAL ARTICLE
Marina Gaeta Gazzola, Lindsay M S Oberleitner, Kim Hoffman, Anthony Eller, Lynn M Madden, Ruthanne Marcus, David Oberleitner, Mark Beitel, Emma Thompson, Xiaoying Zheng, Declan T Barry
BACKGROUND: Community correctional experiences among individuals receiving methadone treatment (MT) for opioid use disorder (OUD) are poorly understood. We qualitatively investigated perceptions of community corrections and treatment experiences among individuals with criminal-legal system experience currently receiving outpatient MT. METHODS: From January to December 2017, we recruited 42 individuals with history of criminal-legal system involvement enrolled in outpatient MT at a low-barrier nonprofit organization operating multiple clinics in Connecticut...
March 29, 2024: Subst Use Addctn J
https://read.qxmd.com/read/38545560/case-report-necrotizing-leukomyelitis-and-meningitis-in-a-pomeranian
#18
Koen M Santifort, Laurent Garosi, Erik A W S Weerts
A 2.5-year-old female entire Pomeranian dog was presented for acute paraparesis progressing within 2 days to paraplegia. General physical examination was unremarkable. Neurological examination showed paraplegia without nociception, a mass reflex upon testing perineal reflexes and withdrawal reflexes in the pelvic limbs and patellar hyperreflexia. Cutaneous trunci reflexes were absent caudal to the level of the 6th thoracic vertebra. Spinal hyperesthesia was present. Neuroanatomical localization was consistent with a T3-L3 myelopathy...
2024: Frontiers in Veterinary Science
https://read.qxmd.com/read/38528570/project-chariot-study-protocol-for-a-hybrid-type-1-effectiveness-implementation-study-of-comprehensive-tele-harm-reduction-for-engagement-of-people-who-inject-drugs-in-hiv-prevention-services
#19
JOURNAL ARTICLE
Tyler S Bartholomew, Marina Plesons, David P Serota, Elizabeth Alonso, Lisa R Metsch, Daniel J Feaster, Jessica Ucha, Edward Suarez, David W Forrest, Teresa A Chueng, Katrina Ciraldo, Jimmie Brooks, Justin D Smith, Joshua A Barocas, Hansel E Tookes
BACKGROUND: People who inject drugs (PWID) remain a high priority population under the federal Ending the HIV Epidemic initiative with 11% of new HIV infections attributable to injection drug use. There is a critical need for innovative, efficacious, scalable, and community-driven models of healthcare in non-stigmatizing settings for PWID. We seek to test a Comprehensive-TeleHarm Reduction (C-THR) intervention for HIV prevention services delivered via a syringe services program (SSP)...
March 25, 2024: Addiction Science & Clinical Practice
https://read.qxmd.com/read/38521571/a-new-coaxial-flow-through-probe-for-electromembrane-extraction-of-methadone-from-clinical-samples-on-line-coupled-to-capillary-electrophoresis
#20
JOURNAL ARTICLE
František Opekar, Petr Tůma
BACKGROUND: A new design of a flow-through coaxial electromembrane extraction (EME) probe that can be on-line coupled with CE instrument is described and tested. The supporting base of the probe is a PDMS microchip with T-shaped channels into which two coaxially arranged capillaries for inlet and outlet solutions are inserted. The extraction part of the probe is a porous polypropylene hollow fiber, sealed at one end and modified with nitrophenyloctyl ether (NPOE) extraction fluid. The internal volume of the extraction probe is 1...
April 29, 2024: Analytica Chimica Acta
keyword
keyword
103212
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.